Aspirin exacerbated respiratory disease (AERD): molecular and cellular diagnostic & prognostic approaches
- 24 February 2021
- journal article
- review article
- Published by Springer Nature in Molecular Biology Reports
- Vol. 48 (3) , 2703-2711
Abstract
Aspirin-exacerbated respiratory disease (AERD) is characterized by immune cells dysfunction. This study aimed to investigate the molecular mechanisms involved in AERD pathogenesis. Relevant literatures were identified by a PubMed search (2005–2019) of english language papers using the terms “Aspirin-exacerbated respiratory disease”, “Allergic inflammation”, “molecular mechanism” and “mutation”. According to the significant role of inflammation in AERD development, ILC-2 is known as the most important cell in disease progression. ILC-2 produces cytokines that induce allergic reactions and also cause lipid mediators production, which activates mast cells and basophils, ultimately. Finally, Monoclonal antibody and Aspirin desensitization in patients can be a useful treatment strategy for prevention and treatment.Keywords
This publication has 70 references indexed in Scilit:
- A genetic effect of IL-5 receptor α polymorphism in patients with aspirin-exacerbated respiratory diseaseExperimental & Molecular Medicine, 2013
- Genome-wide association study of aspirin-exacerbated respiratory disease in a Korean populationHuman Genetics, 2012
- Contribution of the OBSCN Nonsynonymous Variants to Aspirin Exacerbated Respiratory Disease Susceptibility in Korean PopulationDNA and Cell Biology, 2012
- Potential Association ofDCBLD2Polymorphisms with Fall Rates of FEV1by Aspirin Provocation in Korean AsthmaticsJournal of Korean Medical Science, 2012
- Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA# and GA2LEN/HANNA*Allergy, 2011
- On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphomaProstaglandins & Other Lipid Mediators, 2009
- γ‐aminobutyric acid nurtures allergic asthmaClinical & Experimental Allergy, 2009
- Early effects of aspirin desensitization treatment in asthmatic patients with aspirin-exacerbated respiratory diseaseAnnals of Allergy, Asthma & Immunology, 2003
- The natural history and clinical characteristics of aspirin-exacerbated respiratory diseaseAnnals of Allergy, Asthma & Immunology, 2002
- Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory periodJournal of Allergy and Clinical Immunology, 1982